MGTA - Magenta Therapeutics EPS beats by $0.04 May, 06 2021 08:54 AM Magenta Therapeutics Inc. Magenta Therapeutics (MGTA): Q1 GAAP EPS of -$0.36 beats by $0.04.Cash, cash equivalents and marketable securities of $132.29M.Press Release For further details see: Magenta Therapeutics EPS beats by $0.04